{"id":"https://openalex.org/W2410166532","doi":null,"title":"Oxcarbazepine: preliminary clinical and pharmacokinetic studies on a new anticonvulsant.","display_name":"Oxcarbazepine: preliminary clinical and pharmacokinetic studies on a new anticonvulsant.","alternate_titles":[],"publication_year":1987,"publication_date":"1987-01-01","ids":{"openalex":"https://openalex.org/W2410166532","mag":"2410166532","pmid":"https://pubmed.ncbi.nlm.nih.gov/3268334"},"language":"en","primary_location":{"id":"pmid:3268334","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3268334","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and experimental neurology","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W2410166532"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110504366","display_name":"Wayne D Hooper","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"W D Hooper","raw_affiliation_strings":["Department of Medicine, University of Queensland, Brisbane"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of Queensland, Brisbane","institution_ids":["https://openalex.org/I165143802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111553520","display_name":"RONALD G. DICKINSON","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R G Dickinson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036068730","display_name":"Paul R. Dunstan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P R Dunstan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103845532","display_name":"Susan C. Pendlebury","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S C Pendlebury","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5052099914","display_name":"Mervyn John Eadie","orcid":"https://orcid.org/0000-0003-3791-9101","observed_orcids":["https://orcid.org/0000-0003-3791-9101"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M J Eadie","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.4104,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":{"value":0.56547668,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":94},"biblio":{"volume":"24","issue":null,"first_page":"105","last_page":"112"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oxcarbazepine","display_name":"oxcarbazepine","score":1.0},{"id":"https://openalex.org/keywords/carbamazepine","display_name":"carbamazepine","score":0.9309999942779541},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.9229999780654907},{"id":"https://openalex.org/keywords/focal-epilepsy","display_name":"focal epilepsy","score":0.8050000071525574},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8399999737739563},{"id":"https://openalex.org/keywords/prodrugs","display_name":"prodrugs","score":0.8730000257492065},{"id":"https://openalex.org/keywords/hyponatremia","display_name":"hyponatremia","score":0.9020000100135803},{"id":"https://openalex.org/keywords/seizure-control","display_name":"seizure control","score":0.7879999876022339},{"id":"https://openalex.org/keywords/drug-substitution","display_name":"drug substitution","score":0.4480000138282776}],"concepts":[{"id":"https://openalex.org/C2781176495","wikidata":"https://www.wikidata.org/wiki/Q176301","display_name":"Oxcarbazepine","level":4,"score":0.9658146500587463},{"id":"https://openalex.org/C2779253243","wikidata":"https://www.wikidata.org/wiki/Q410412","display_name":"Carbamazepine","level":3,"score":0.8420615196228027},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.7997560501098633},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7849529981613159},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7008134126663208},{"id":"https://openalex.org/C192670549","wikidata":"https://www.wikidata.org/wiki/Q5361061","display_name":"Elimination rate constant","level":4,"score":0.6982545256614685},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6278117299079895},{"id":"https://openalex.org/C139254425","wikidata":"https://www.wikidata.org/wiki/Q1332167","display_name":"Volume of distribution","level":3,"score":0.5479927659034729},{"id":"https://openalex.org/C149151106","wikidata":"https://www.wikidata.org/wiki/Q4677569","display_name":"Active metabolite","level":3,"score":0.5398368835449219},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.48882314562797546},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4573255777359009},{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.4447786211967468},{"id":"https://openalex.org/C2778802184","wikidata":"https://www.wikidata.org/wiki/Q410346","display_name":"Lamotrigine","level":3,"score":0.44096970558166504},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.4340102970600128},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2518264353275299},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000078330","descriptor_name":"Oxcarbazepine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002220","descriptor_name":"Carbamazepine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D002220","descriptor_name":"Carbamazepine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D002220","descriptor_name":"Carbamazepine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004827","descriptor_name":"Epilepsy","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004827","descriptor_name":"Epilepsy","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:3268334","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3268334","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and experimental neurology","raw_type":"Journal Article"},{"id":"mag:2410166532","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3268334","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3624395","https://openalex.org/W2079515082","https://openalex.org/W2086608015","https://openalex.org/W2414456084","https://openalex.org/W1989869913","https://openalex.org/W2086161839","https://openalex.org/W2093386822","https://openalex.org/W4240301829","https://openalex.org/W2356298227","https://openalex.org/W1985206067"],"abstract_inverted_index":{"Oxcarbazepine":[0,210],"is":[1],"a":[2,34,98,168,194,214,234],"new":[3],"anticonvulsant,":[4,221],"currently":[5],"undergoing":[6],"clinical":[7],"trials.":[8],"Its":[9],"spectrum":[10],"of":[11,20,36,46,82,105,138,172,182,206,225],"antiepileptic":[12],"action,":[13],"and":[14,56,65,85,177],"its":[15,86,226,237],"chemical":[16],"structure,":[17],"resemble":[18],"those":[19,205],"carbamazepine,":[21],"though":[22],"the":[23,83,103,115,165,207],"2":[24],"drugs":[25],"have":[26],"no":[27,76],"pharmacologically":[28,87],"active":[29,88],"metabolites":[30],"in":[31,54,58,107,223],"common.":[32],"In":[33],"study":[35],"7":[37],"adults":[38],"with":[39,193],"poorly":[40],"controlled":[41],"partial":[42],"epilepsy,":[43],"progressive":[44],"substitution":[45],"oxcarbazepine":[47],"for":[48,114,236],"carbamazepine":[49,218],"left":[50],"seizure":[51],"control":[52],"unaltered":[53],"4":[55,95],"improved":[57],"3,":[59],"whilst":[60],"5":[61,108],"became":[62,72],"more":[63],"alert":[64],"one":[66],"was":[67],"rendered":[68],"ataxic.":[69],"Three":[70],"subjects":[71],"hyponatraemic.":[73],"There":[74],"were":[75,91,201],"other":[77],"adverse":[78],"effects.":[79],"Plasma":[80],"levels":[81,200],"drug":[84,100],"10-hydroxy":[89,238],"derivative":[90],"measured":[92],"sequentially":[93],"over":[94],"days":[96],"after":[97],"single":[99,195],"dose":[101],"at":[102],"outset":[104],"therapy":[106],"subjects.":[109],"Calculated":[110],"pharmacokinetic":[111],"parameter":[112],"values":[113],"drug,":[116],"assuming":[117],"complete":[118],"oral":[119,145],"bioavailability,":[120],"were:":[121],"absorption":[122,129],"lag":[123],"time":[124],"2.07":[125],"+/-":[126,133,141,148,156,161,174,184,189],"1.61":[127],"h:":[128],"rate":[130,153,170,180],"constant":[131,154,171,181],"8.328":[132],"8.941":[134],"h-1:":[135],"apparent":[136],"volume":[137],"distribution":[139],"3.937":[140],"2.222":[142],"L":[143,150],"kg-1:":[144,151],"clearance":[146],"2.898":[147],"1.439":[149],"elimination":[152,179,228],"0.609":[155],"0.261":[157],"h-1":[158,186],"(half-life":[159,187],"1.26":[160],"0.37":[162],"h),":[163],"while":[164],"metabolite":[166,199],"had":[167],"formation":[169],"0.593":[173],"0.233":[175],"h-1,":[176],"an":[178,220],"0.082":[183],"0.014":[185],"8.74":[188],"1.79":[190],"h).":[191],"Even":[192],"dose,":[196],"peak":[197],"plasma":[198],"substantially":[202],"higher":[203],"than":[204],"parent":[208],"drug.":[209],"appears":[211],"to":[212,217],"be":[213],"promising":[215],"alternative":[216],"as":[219,233],"although":[222],"view":[224],"rapid":[227],"it":[229],"probably":[230],"serves":[231],"mainly":[232],"prodrug":[235],"metabolite.":[239]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2410166532","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
